MX2009011079A - Metodo para la determinacion del riesgo del inicio de glaucoma. - Google Patents

Metodo para la determinacion del riesgo del inicio de glaucoma.

Info

Publication number
MX2009011079A
MX2009011079A MX2009011079A MX2009011079A MX2009011079A MX 2009011079 A MX2009011079 A MX 2009011079A MX 2009011079 A MX2009011079 A MX 2009011079A MX 2009011079 A MX2009011079 A MX 2009011079A MX 2009011079 A MX2009011079 A MX 2009011079A
Authority
MX
Mexico
Prior art keywords
glaucoma
allele
risk
genotype
nucleotide sequence
Prior art date
Application number
MX2009011079A
Other languages
English (en)
Inventor
Shigeru Kinoshita
Kei Tashiro
Masakazu Nakano
Tomohito Yagi
Kazuhiko Mori
Yoko Ikeda
Takazumi Taniguchi
Masaaki Kageyama
Original Assignee
Kei Tashiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kei Tashiro filed Critical Kei Tashiro
Publication of MX2009011079A publication Critical patent/MX2009011079A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se da a conocer un método para la determinación de la presencia o ausencia de riesgo de glaucoma, el cual comprende los pasos que consisten en: detectar in vitro un alelo y/o un genotipo de un polimorfismo de un solo nucleótido que se presenta en la posición-31 en por lo menos una secuencia de nucleótidos seleccionada del grupo que consiste de las secuencias de nucleótidos representadas en las SEQ ID NOs: 203-514 o una secuencia de nucleótidos complementaria para por lo menos la secuencia de nucleótidos en una muestra recolectada de un sujeto (paso A); y comparar el alelo y/o el genotipo detectado en el paso A con por lo menos un alelo y/o genotipo que contiene un alelo de alto riesgo en una secuencia de nucleótidos representada en cualquiera de las SEQ ID NOs: 203-514 (paso B). El nivel de riesgo del inicio de glaucoma en un donador de una muestra se puede determinar al analizar el alelo o genotipo del polimorfismo de un solo nucleótido en la muestra por medio del método. Con base en el nivel de riesgo, el donador puede adoptar una medida preventiva para el glaucoma o recibir un tratamiento apropiado para el glaucoma.
MX2009011079A 2007-04-17 2008-04-17 Metodo para la determinacion del riesgo del inicio de glaucoma. MX2009011079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007108688 2007-04-17
PCT/JP2008/057527 WO2008130008A1 (ja) 2007-04-17 2008-04-17 緑内障発症リスクの判定方法

Publications (1)

Publication Number Publication Date
MX2009011079A true MX2009011079A (es) 2010-03-10

Family

ID=39875536

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009011079A MX2009011079A (es) 2007-04-17 2008-04-17 Metodo para la determinacion del riesgo del inicio de glaucoma.
MX2009011080A MX2009011080A (es) 2007-04-17 2008-04-17 Metodo para la determinacion del riesgo del avance de glaucoma.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009011080A MX2009011080A (es) 2007-04-17 2008-04-17 Metodo para la determinacion del riesgo del avance de glaucoma.

Country Status (12)

Country Link
US (4) US8431345B2 (es)
EP (4) EP2565270A1 (es)
JP (5) JP5624763B2 (es)
KR (2) KR20100016568A (es)
CN (2) CN101679971A (es)
AU (2) AU2008241867A1 (es)
BR (2) BRPI0810425A2 (es)
CA (2) CA2683691A1 (es)
MX (2) MX2009011079A (es)
RU (2) RU2009142225A (es)
SG (2) SG177960A1 (es)
WO (2) WO2008130009A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG158776A1 (en) * 2008-07-25 2010-02-26 Univ Kaohsiung Medical Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia
JP4515524B2 (ja) * 2008-11-27 2010-08-04 株式会社メニコン 正常眼圧緑内障疾患感受性遺伝子及びその利用
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US20120122703A1 (en) * 2009-07-03 2012-05-17 University College Cardiff Consultants Limited Diagnosis and treatment of alzheimer's disease
US9107617B2 (en) 2009-11-16 2015-08-18 Agency For Science, Technology And Research Obtaining data for automatic glaucoma screening, and screening and diagnostic techniques and systems using the data
WO2011152098A1 (ja) * 2010-06-04 2011-12-08 コニカミノルタエムジー株式会社 イムノクロマトグラフ法のための展開液およびそれを用いた測定法
US9708664B2 (en) 2012-04-20 2017-07-18 University Of Virginia Patent Foundation Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure
EP2888718B1 (en) 2012-08-24 2018-01-17 Agency For Science, Technology And Research Methods and systems for automatic location of optic structures in an image of an eye, and for automatic retina cup-to-disc ratio computation
US10648035B2 (en) 2012-11-26 2020-05-12 The Johns Hopkins University Methods and compositions for diagnosing and treating gastric cancer
RU2508043C1 (ru) * 2012-12-20 2014-02-27 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития открытоугольной глаукомы у пациентов с глазными проявлениями псевдоэксфолиативного синдрома
US20150315645A1 (en) * 2014-05-03 2015-11-05 The Regents Of The University Of California Methods of identifying biomarkers associated with or causative of the progression of disease
RU2580306C1 (ru) * 2015-03-26 2016-04-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития первичной открытоугольной глаукомы у индивидуумов в зависимости от наличия/отсутствия сопутствующих неинфекционных заболеваний глаз
RU2585381C1 (ru) * 2015-03-27 2016-05-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования показателей гидродинамики у больных первичной открытоугольной глаукомой
JP6542037B2 (ja) * 2015-06-04 2019-07-10 シスメックス株式会社 関節リウマチ患者におけるメトトレキサートの有効性の診断を補助する方法
JP7072803B2 (ja) * 2016-06-30 2022-05-23 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
JP7064215B2 (ja) * 2016-08-05 2022-05-10 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法
WO2020002602A1 (fr) 2018-06-29 2020-01-02 bioMérieux Procédé pour déterminer in vitro ou ex vivo le statut immunitaire d'un individu
EP4042426A1 (en) * 2019-10-31 2022-08-17 Google LLC Using machine learning-based trait predictions for genetic association discovery
CN113444788B (zh) * 2021-08-27 2021-11-02 中国医学科学院北京协和医院 青光眼诊断产品及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5686407A (en) * 1995-08-16 1997-11-11 Alcon Laboratories, Inc. Hepatocyte growth factor to treat glaucoma
US5962230A (en) * 1997-02-13 1999-10-05 The University Of Connecticut Diagnosis and treatment of glaucoma
JP2000306165A (ja) 1999-02-19 2000-11-02 Toshiba Tec Corp 医療費控除用レシート発行装置および記録媒体
JP2002306165A (ja) 2000-05-17 2002-10-22 Tsubota:Kk 正常眼圧緑内障を含む開放隅角緑内障の関連遺伝子
WO2005090602A2 (en) 2004-03-18 2005-09-29 Sucampo Ag Method for diagnosing or predicting susceptibility to optic nueropathy
EP1647600A3 (en) * 2004-09-17 2006-06-28 Affymetrix, Inc. (A US Entity) Methods for identifying biological samples by addition of nucleic acid bar-code tags
NZ576591A (en) 2006-10-27 2012-04-27 Decode Genetics Efh Cancer susceptibility variants on chr8q24.21
US20100240057A1 (en) * 2007-11-08 2010-09-23 St. Jude Children's Research Hospital Methods and compositions for the diagnosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia

Also Published As

Publication number Publication date
US20130210668A1 (en) 2013-08-15
CA2683691A1 (en) 2008-10-30
US20130012408A1 (en) 2013-01-10
JPWO2008130009A1 (ja) 2010-07-22
EP2147975A4 (en) 2010-11-10
SG177960A1 (en) 2012-02-28
JP2013150628A (ja) 2013-08-08
JPWO2008130008A1 (ja) 2010-07-22
AU2008241867A1 (en) 2008-10-30
JP6203217B2 (ja) 2017-09-27
WO2008130009A1 (ja) 2008-10-30
US8431345B2 (en) 2013-04-30
EP2161334A4 (en) 2010-11-10
JP2017201995A (ja) 2017-11-16
CN101679970A (zh) 2010-03-24
MX2009011080A (es) 2010-03-10
CN101679971A (zh) 2010-03-24
RU2009142225A (ru) 2011-05-27
US20110207122A1 (en) 2011-08-25
BRPI0810071A2 (pt) 2014-10-14
JP5624763B2 (ja) 2014-11-12
WO2008130008A1 (ja) 2008-10-30
RU2009142223A (ru) 2011-05-27
EP2548961A1 (en) 2013-01-23
EP2147975A1 (en) 2010-01-27
KR20100016568A (ko) 2010-02-12
US20100196895A1 (en) 2010-08-05
EP2565270A1 (en) 2013-03-06
JP2015180219A (ja) 2015-10-15
KR20100016525A (ko) 2010-02-12
AU2008241868A1 (en) 2008-10-30
SG177968A1 (en) 2012-02-28
CA2683836A1 (en) 2008-10-30
JP5759500B2 (ja) 2015-08-05
EP2161334A1 (en) 2010-03-10
BRPI0810425A2 (pt) 2014-10-07

Similar Documents

Publication Publication Date Title
MX2009011079A (es) Metodo para la determinacion del riesgo del inicio de glaucoma.
HK1125416A1 (en) Dna conformation (loop structures) in normal and abnormal gene expression
RU2017100015A (ru) Набор или устройство для обнаружения рака желчных путей и способ обнаружения
WO2006088910A3 (en) Sequence-specific detection of nucleotide sequences
NZ589863A (en) Genetic markers for weight management and methods of use thereof
NZ625565A (en) Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
WO2012170725A3 (en) Materials and method for identifying spinal muscular atrophy carriers
WO2010096202A3 (en) Sequence-specific detection of nucleotide sequences
NZ601652A (en) Set of probes for the detection and typing of 46 human papillomavirus mucosal types
NZ587903A (en) Susceptibility for lung cancer using the polymorphic marker rs1051730
WO2008137121A3 (en) Methods for detecting an increased risk for coronary heart disease
ES2638294T3 (es) Método de detección de cáncer
TW200801200A (en) Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist
WO2013132074A3 (en) A genotyping test for assessing risk of autism
EP1988178A3 (en) Nucleotide primer set and nucleotide probe for detecting genotype of serum amyloid A1(SAA1)
NZ591711A (en) A method for predicting athletic performance potential
WO2009153667A3 (en) Method for the detection of ovarian cancer
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
UA118676C2 (uk) СПОСІБ ВИЯВЛЕННЯ РОСЛИНИ Zea mays, ЯКА МІСТИТЬ ЩОНАЙМЕНШЕ ОДИН АЛЕЛЬ, АСОЦІЙОВАНИЙ З ОПТИМІЗАЦІЄЮ ВОДОСПОЖИВАННЯ
EP1975249A3 (en) Nucleotide primer set and nucleotide probe for detecting genotype of N-acetyltransferase 2 (NAT2)
WO2011020906A3 (en) sPLA2 IIA POLYMORPHISM ANALYSIS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT
WO2012135146A3 (en) Role of ifng methylation in inflammatory bowel disease
WO2008048902A3 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2009007726A3 (en) Abnormal blood conditions
WO2007128984A3 (en) Breast cancer makers

Legal Events

Date Code Title Description
FA Abandonment or withdrawal